335 related articles for article (PubMed ID: 16199884)
21. The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
Awasthi S; Ezelle H; Hassel BA; Hamburger AW
Mol Cell Biochem; 2015 Jul; 405(1-2):177-86. PubMed ID: 25876877
[TBL] [Abstract][Full Text] [Related]
22. An ERBB3/ERBB2 oncogenic unit plays a key role in NRG1 signaling and melanoma cell growth and survival.
Zhang K; Wong P; Duan J; Jacobs B; Borden EC; Bedogni B
Pigment Cell Melanoma Res; 2013 May; 26(3):408-14. PubMed ID: 23480537
[TBL] [Abstract][Full Text] [Related]
23. Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis.
Kawano S; Mizutani K; Miyata M; Ikeda W; Takai Y
Genes Cells; 2010 Sep; 15(9):995-1001. PubMed ID: 20695903
[TBL] [Abstract][Full Text] [Related]
24. In vivo knockdown of ErbB3 in mice inhibits Schwann cell precursor migration.
Torii T; Miyamoto Y; Takada S; Tsumura H; Arai M; Nakamura K; Ohbuchi K; Yamamoto M; Tanoue A; Yamauchi J
Biochem Biophys Res Commun; 2014 Sep; 452(3):782-8. PubMed ID: 25204498
[TBL] [Abstract][Full Text] [Related]
25. ErbB3-ErbB2 Complexes as a Therapeutic Target in a Subset of Wild-type BRAF/NRAS Cutaneous Melanomas.
Capparelli C; Rosenbaum S; Berman-Booty LD; Salhi A; Gaborit N; Zhan T; Chervoneva I; Roszik J; Woodman SE; Davies MA; Setiady YY; Osman I; Yarden Y; Aplin AE
Cancer Res; 2015 Sep; 75(17):3554-67. PubMed ID: 26206558
[TBL] [Abstract][Full Text] [Related]
26. ERBB2 Overexpression Establishes ERBB3-Dependent Hypersensitivity of Breast Cancer Cells to Withaferin A.
Liu W; Barnette AR; Andreansky S; Landgraf R
Mol Cancer Ther; 2016 Nov; 15(11):2750-2757. PubMed ID: 27474152
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-assisted receptor deletion reveals distinct roles for ERBB2 and ERBB3 in skin keratinocytes.
Dahlhoff M; Gaborit N; Bultmann S; Leonhardt H; Yarden Y; Schneider MR
FEBS J; 2017 Oct; 284(19):3339-3349. PubMed ID: 28805349
[TBL] [Abstract][Full Text] [Related]
29. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
30. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
[TBL] [Abstract][Full Text] [Related]
31. Dynamic analysis of the epidermal growth factor (EGF) receptor-ErbB2-ErbB3 protein network by luciferase fragment complementation imaging.
Macdonald-Obermann JL; Adak S; Landgraf R; Piwnica-Worms D; Pike LJ
J Biol Chem; 2013 Oct; 288(42):30773-30784. PubMed ID: 24014028
[TBL] [Abstract][Full Text] [Related]
32. Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation.
Kwon NH; Lee MR; Kong J; Park SK; Hwang BJ; Kim BG; Lee ES; Moon HG; Kim S
RNA Biol; 2018; 15(4-5):635-648. PubMed ID: 28816616
[TBL] [Abstract][Full Text] [Related]
33. ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.
Stern DF
J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):215-23. PubMed ID: 18454306
[TBL] [Abstract][Full Text] [Related]
34. Neuregulin 1 up-regulates the expression of nicotinic acetylcholine receptors through the ErbB2/ErbB3-PI3K-MAPK signaling cascade in adult autonomic ganglion neurons.
Kim HG; Lee CK; Cho SM; Whang K; Cha BH; Shin JH; Song KH; Jeong SW
J Neurochem; 2013 Feb; 124(4):502-13. PubMed ID: 23199222
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase A-mediated gating of neuregulin-dependent ErbB2-ErbB3 activation underlies the synergistic action of cAMP on Schwann cell proliferation.
Monje PV; Athauda G; Wood PM
J Biol Chem; 2008 Dec; 283(49):34087-100. PubMed ID: 18799465
[TBL] [Abstract][Full Text] [Related]
36. erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.
Steinkamp MP; Low-Nam ST; Yang S; Lidke KA; Lidke DS; Wilson BS
Mol Cell Biol; 2014 Mar; 34(6):965-77. PubMed ID: 24379439
[TBL] [Abstract][Full Text] [Related]
37. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
[TBL] [Abstract][Full Text] [Related]
38. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
Gordon-Thomson C; Jones J; Mason RS; Moore GP
Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
[TBL] [Abstract][Full Text] [Related]
39. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
40. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.
Zhang Q; Park E; Kani K; Landgraf R
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
